According to the current analysis of Reports and Data, the global fertility testing market was valued at 467.6 Million in 2020 and is expected to reach USD 796.1 Million by the year 2028, at a CAGR of 6.8%. Fertility testing market is rising due to delay in pregnancy, and due to the late pregnancy cases, as after crossing the age of 30, female decreases the chance of conceiving and further till the age of 35, the chance of conceiving further declines. Due to this, there is a fewer number of eggs left in the ovaries, which leads to irregular or absence of a menstrual cycle, PCOS POI further proceeds for infertility. Damaged sperm is the most common cause of male infertility. The factors driving the industry includes the rise in PCOS disorders, increasing primary ovarian insufficiency (POI) and low sperm motility.

Fertility kits are developed to check fertility in which mostly the ovulation test kits are used, for detecting luteinizing hormone (LH) level and sometimes even estrogen levels to predict the ovulation. These kits, however, do not provide exact information about ovulation. The luteinized unruptured follicle syndrome ovulation predictor fails to give proper results. Also, LH measurement predicts ovulation and cannot determine the date of ovulation or anovulation. The leading manufacturers in the industry are Clearblue (Swiss Precision Diagnostics GmbH), First Response, and Prestige.

Market Overview:

The pharma and healthcare industry is at a crossroads. Patients are benefiting from the promise of cell and gene therapies; uncommon diseases that were previously thought to be incurable are on the verge of finding true treatments. Artificial intelligence (AI) and machine-learning technologies are creating hopes that therapy discovery and development would be more innovative, as well as faster and cheaper. Manufacturing, the supply chain, and the entire healthcare ecosystem all have the potential to benefit from data-driven initiatives. Consumer attitudes and behaviours are shifting in a variety of ways, from growing use of technology and willingness to share data to an interest in using tools to make prescription and treatment decisions. Such factors will drive pharma and healthcare market growth in the coming years.

Some key highlights of the report:

• Fertility testing market will be expanding with the increase in the number of equipment with digitalized testing, and modern fertility testing that provides data associated to hormone levels. It tracks fertility markers over a period and, creates an individualized fertility curve that gives women more information about their ovarian eggs and details about menopause.
• Telehealth solutions are a boom to the fertility testing market, the testing is done using an ovulation kit, and further, the consulting can be done through a camera video, etc.
• In the year 2020, Predictive Technology Group, Inc. had launched endometriosis risk test ARTguide. It is a noninvasive diagnostic test and was associated with detecting various genetic and endometriosis which was further leading to infertility.
• In July 2020, Merck KGaA had launched (Fertility.com), which enabled healthcare professionals and doctors to access the latest researches and scientific information and was also a help to those who were undergoing fertility treatment, this positioned Merck to be the market leader.
• Microbiome modulation has made advances to treat infertility. The Co-founders of Microgenesis have created an infertility diagnosis and treatment for the complicated issues associated with fertility. That is mostly due to immunological problems. Preventive treatment includes the biomedical diet, which contains amino acids, minerals, probiotics, and vitamins.
• Sperm count kits have also been discovered, for instance, YO Sperm Test is an home testing kit which allows to check and analyze the sperm count and motility and also visualizes the sperm in the form of the video.
• Obese women are likely to suffer from infertility. Even after getting pregnant there are chances of miscarriages, fetal death, and premature delivery and due to this reason the IVI technique is used so that it will improve the chances for fertilization.
• IVM (In Vitro Maturation) is a procedure where immature eggs from a woman are allowed to grow in a lab, and after the eggs are mature, they’re fertilized and implanted. This process has the potential to help women with certain gynecological disorders to have children.

Key Players covered in this report are

Advacare Pharma (U.S.), AVA, Babystart (UK), Fertility Focus (UK), Geratherm Medical (Germany), Hilin Life Products (U.S.), Sensiia (UK), Taidoc, Medical Uebe (Germany), Valley Electronics (Switzerland)   

Product Outlook (Revenue in Million USD; 2020–2028)

• Ovulation test kits
• Saliva Strip Based
• Monitor Touch Screen
• Fertility monitors
• Urine-Based Monitors
• Pregnancy Rapid Test
• Line Indicators
• Strip/Dip Sticks
• Mid-Stream Device
• Cassettes
• Other Fertility Monitors
• Basal Body Temperature,
• Cervical Mucus,
• Perspiration Monitoring
• Male Fertility Testing Product

Mode of Purchase Outlook (Revenue in Million USD; 2020–2028)

• OTC Non Prescription
• Prescription based

Type Outlook (Revenue in Million USD; 2020–2028)

• HCG Blood test
• HCG Urine test
• FSH Urine test

Application Outlook (Revenue in Million USD; 2020–2028)

• Female fertility testing
• Male Fertility Testing

Distribution Channel Outlook (Revenue in Million USD; 2020–2028)

• Pharmacies
• Drugstores
• Online Sales
• Hypermarkets Supermarkets

End Use Outlook (Revenue in Million USD; 2020–2028)

• Home care
• Hospitals, Fertility Clinics,
• Others

Major Points covered in this report are as below:

 The  Fertility Testing Market industry development trends and marketing channels are analyzed. The feasibility of new investment projects are assessed and overall research conclusions offered.

 With the tables and figures, the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

 Development policies and plans, manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand figures, cost, price, revenue and gross margins.

 The  Fertility Testing Market Market report provides key statistics on the market status of the  Fertility Testing Market manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

We can also provide the customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central South America, Brazil, Argentina, Rest of South America, Middle East Africa, Saudi Arabia, Turkey, Rest of Middle East Africa

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2510               

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.